Abstract
The issue of bacterial resistance to current classes of antibiotics is now well known and widely published (Levy, 1998; Chin and Marx, 1994). Indeed, unbeatable contagious infectious diseases have already generated significant medical crises in localized environments. Such crises may become more widespread, perhaps in the not too distant future. Laboratories worldwide have responded with highly creative research programs, many of which are reviewed in this book. Nonetheless, the successful discovery, development, and commercialization of new therapies that address bacterial resistance have proved challenging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albrecht, H.A., Beskid, G., Chan, K., Christenson, J.G., Cleeland, R., Deitcher, K.H., Georgopapadakou, N.H., Keith, D.D., Pruess, D.L., Sepinwall, J., Specian, Jr., A.C., Then, R.L., Weigele, M., West, K.F., Yang, R., 1990, Cephalosporin 3′-quinolone esters with a dual mode of action, J. Med. Chem, 33:77–86.
Albrecht, H.A., Beskid, G., Christenson, J.G., Deitcher, K.H., Georgopapadakou, N.H., Keith, D.D., Konzelmann, F.M., Pruess, D.L., and Wei, C.C., 1994, Dual-action cephalosporins incorporating a 3′-tertiary-amine-linked quinolone, J. Med. Chem, 37:400–7.
Albrecht, H.A., Beskid, G., Christenson, J.G., Durkin, J.W., Fallat, V., Georgopapadakou, N.H., Keith, D.D., Konzelmann, F., Lipschutz, E.R., McGarry, D.H., Siebelist, J. A., Wei, C.-C., Weigele, M., and Yang, R., 1991, Dual-action cephalosporins:cephalosporin3′-quaternaryammoniumquinolones, J. Med. Chem, 34:669–75.
Albrecht, H.A., Beskid, G., Christenson, J.G., Georgopapadakou, N.H., Keith, D.D., Konzelmann, F.M., Pruess, D.L., Rossman, P.L., and Wei, C.-C., 1991, Dual-action cephalosporin 3′-quinolone carbamates, J. Med. Chem, 34:2857–64.
Albrecht, H.A., and Christenson, J.G., 1992, Mechanism-based dual-action cephalosporins, Adv. Med. Chem, 1:207–34.
Alexander, R.P., Bates, R.W., Pratt, A.J., and (in part) Kraunsoe, J.A.E., 1996, A N-nitrosochloroethyl-cepha-losporin carbamate prodrug for antibody-directed enzyme prodrug therapy (ADEPT), Tetrahedron, 52(16):5983–8.
Alexander, R.P., Beeley, N.R.A., O’Driscoll, M., O’Neill, F.P., Millican, T.A., Pratt, A.J., and Willenbrock, F.W., 1991, Cephalosporin nitrogen mustard carbamate prodrugs for ADEPT, Tetrahedron Lett, 32(27):3269–72.
Alpegiani, M., Bedeschi, A., Perrone, E., Zarini, F., and Franceschi, G., 1985, 2-(Heteroatom-substituted)methyl penems. I. Sulphur derivatives, Heterocycles, 23:2255–70.
Beskid, G., Albrecht, H.A., Fallat, V., Keith, D.D., Lipschutz, E.R., McGarry, S.M., McGarry, D.H., Rossman, P., and Siebelist, J.A., 1991, In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383, J. Chemother, 37:310–7.
Beskid, G., Siebelist, J.A., McGarry, C.M., Cleeland, R., Chan, K., and Keith, D.D., 1990, In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin, Chemother, 36:109–16.
Bierman, J.C., Mallalieu, N.L., Walling, M.A., Kuzmak, B.R., Emig, J.E., Dirr, M.K., Tirey, D.A., Zoutendam, P.H., White, R.E., Gray, J.L., Matson, P.A., Ma, X., Kraft, W.G., Demuth, Jr., T.P., and Leunk, R.D., 1997, In vivo efficacy and pharmacodynamics of four quinolonyl-lactam antibacterial agents in mice, 37th Inter-science Conf. Antimicrobial Agents Chemother, Abstr. No. F197, Toronto, Canada.
Bonjouklian, R., and Phillips, M.L., 1981, Reactions of TMSI with cephalosporin esters, Tetrahedron Lett, 22:3915–8.
Bouzard, D., Cesare, P.D., Essiz, M., Jacquet, J.P., Kiechel, J.R., Remuzon, P., Weber, A., Oki, T., Masuyoshi, M., Kessler, R.E., Fung-Tomc, J., and Desiderio, J., 1990, Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives, J. Med. Chem, 33:1344–52.
Boyd, D.B., Hermann, R.B., Presti, D.E., and Marsh, M.M., 1975, Electronic structures of cephalosporins and penicillins. 4. Modeling acylation by the β-lactam ring, J. Med. Chem, 18(4):40617.
Boyd, D.B., and Lunn, W.H.W., 1979, Electronic structures of cephalosporins and penicillins. 9. Departure of a leaving group in cephalosporins, J. Med. Chem, 22(7):778–84.
Chin, G.J., and Marx, J., 1994, Resistance to antibiotics, Science, 264:359.
Christenson, J.G., Beskid, G., Cleeland, R., Farrish, Jr., H.H., Holzknecht, B.D., Keith, D.D., Pruess, D.L., and Talbot, M.K., 1990, Pharmacokinetic and mechanistic differences between ester-and carbamate-1 inked dual-action cephalosporins, 30th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. 405, Atlanta, GA.
Christenson, J.G., Chan, K.K., Cleeland, R., Dix-Holzknecht, B., Farrish, Jr., H.H., Patel, I.H., and Specian, A., 1990, Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals, Antimicrob. Agents Chemother, 34(10): 1895–1900.
Cocker, J.D., Cowley, B.R., Cox, J.S.G., Eardley, S., Gregory, G.I., Lazenby, J.K., Long, A.G., Sly, J.C.P., and Somerfield, G.A., 1965, Cephalosporin acids. Part II. Displacement of the acetoxy group by nucleophiles, J. Chem.Soc, 5015–31.
Cook, G.K., Hornback, W.J., Jordan, C.L., McDonald III, J.H., and Munroe, J.E., 1989, Palladium-catalyzed chemistry of β-lactam vinyl triflates: coupling with organostannanes and alkoxycarbonylation, J. Org. Chem, 54:5828–30.
Corraz, A.J., Dax, S.L., Dunlap, N.K., Georgopapadakou, N.H., Keith, D.D., Pruess, D.L., Rossman, P.L., Then, R., Unowsky, J., and Wei, C.-C., 1992, Dual-action penems and carbapenems, J. Med. Chem, 35:1828–39.
Dax, S.L., 1992, Dual-action β-lactam antibacterials, Current Opinion in Therapeutic Patents, Antimicrobials, September: 1375–84.
Dax, S.L., Pruess, D.L., Rossman, P.L., and Wei, C.-C., 1993, Synthesis and mechanistic studies of a ‘tetrazole-tethered’ cephalosporin-quinolone hybrid, Bioorg. Med. Chem. Lett, 3(2):209–14.
Demuth, Jr., T.P., Berk, J.D., Davis, B.W., Koenigs, P.M., Kraft, W.G., McOsker, C.C., Rourke, F.J., Shinabarger, D.L., Tietjen, R.A., and White, R.E.. 1993, Preclinical evaluation of quinolonyi-lactam antibacterials: compounds designed to combat drug-resistance in bacteria, Eastern Pennsylvania Branch of American Society of Microbiology Symposium, Nov. 11–12, Philadelphia, PA.
Demuth, Jr., T.P., White, R.E., Tietjen, R.A., Ebetino, F.H., Kraft, W.G., Andersen, J.A., McOsker, C.C., Walling, M.A., Davis, B.W., and Rourke, F.J., 1990, C-10 Quinolonyl-eephem carbamates: synthesis, and evaluation of a new class of antibacterial agents, 200th ACS Meeting, Abstr. No. MEDI-154.
Demuth, Jr., T.P., White, R.E., Tietjen, R.A., Pollack, J.R., Kraft, W.G., Davis, B.W., and Rourke, F.J., 1992, Preparation and antimicrobial activity of novel C-10 quinolonyl-cephem dithiocarbamates, 32th Inter-science Conf Antimicrob. Agents Chemother, Abstr. No. 773, Anaheim, CA.
Demuth, Jr., T.P., White, R.E., Tietjen, R.A., Storrin, R.J., Skuster, J.R., Andersen, J.A., McOsker, C.C., Freedman, R., and Rourke, F.J., 1991, Synthesis and antibacterial activity of new C-10 quinolonyl-cephem esters, J. Antibiotics, 44:200–9.
Domagala, J.M., Hagen, S.E., Joannides, T., Kiely, J.S., Laborde, E., Schroeder, M.C., Sesnie, J.A., Shapiro, M.A., Suto, M.J., and Vanderroest, S., 1993, Quinolone antibacterial containing the new 7-[3-(1-aminoethyl)-1-pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy, J. Med. Chem, 36:871–82.
Ehrhardt, A.F., and Saunders, C., 1997, Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli, Antimicrob. Agents Chemother, 41(11):2570–2.
Faraci, W.S., and Pratt, R.F., 1984, Elimination of a good leaving group from the 3′-position of a cephalosporin need not be concerted with β-lactam ring opening: TEM-2 β-lactamase-catalyzed hydrolysis of pyridine-2-azo-4’,-(N’, N’-dimethylaniline) cephalosporin (PADAC) and of cephaloridine, J. Am. Chem. Soc, 106:1489–90.
Perrone, E., Jabes, D., Alpegiani, M., Andreini, B.P., Bruna, C.D., Nero, S.D., Rossi, R., Visentin, G., Zarini, F., and Franceschi, G., 1992, Dual-action penems, J. Antibiotics, 45(4):589–94.
Georgopapadakou, N.H., and Bertasso, A., 1993, Mechanisms of action of cephalosporin S′-quinolone esters, carbamates, and tertiary amines in Escherichia coli, Antimicrob. Agents Chemother, 37(3):559–65.
Georgopapadakou, N.H., Bertasso, A., Chan, K.K., Chapman, J.S., Cleeland, R., Cummings, L.M., Dix, B.D., and Keith, D.D. 1989, Mode of action of the dual-action cephalosporin Ro 23-9424, Antimicrob. Agents Chemother, 33(7): 1067–71.
Gray, J.L., Shrum, G.P., Gasparski, C.M., Wang, A.M., Ramberger, N.R., Davis, B.W., McKeever, H.D., Koenigs, P.M., Paule, S.M., Twinem, T.L., Kraft, W.G., Rourke, F.J., and Demuth, Jr., T.P., 1995, Antibacterial activity of multifunctional quinolonyl-eephem 2°-amines, 35th Interscience Conf Antimicrob. Agents Chemother, San Francisco, CA.
Gu, J.-W., and Neu, H.C., 1990, In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics, Antimicrob. Agents Chemother, 34(2): 189–95.
Hamilton-Miller, J.M.T., Newton, G.G.F., and Abraham, E.P., 1970, Products of aminolysis and enzymic hydrolysis of the cephalosporins, Biochem. J, 116:371–84.
Hamilton-Miller, J.M.T., Richards, E., and Abraham, E.P., 1970, Changes in proton-magnetic-resonance spectra during aminolysis and enzymic hydrolysis of cephalosporins, Biochem J, 116:385–95.
Hanessian, S., and Wang, J., 1993, Design and synthesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase, Can. J. Chem, 71:896–906.
Hershberger, P.M., Switzer, A.G., Yelm, K.E., Coleman, M.C., DeVries, C.A., Rourke, F.J., Davis, B.W., Kraft, W.G., Twinem, T.L., Koenigs, P.M., Paule, S.M., Siehnel, R.J., Zoutendam, P.H., Imbus, R., and Demuth, Jr., T.P., 1996, Synthesis and biological evaluation of 2-thioether-linked quinolonyl carbapenems, 36th Interscience Conf Antimicrob. Agents Chemother, Abstr. No. F170, New Orleans, LA.
Hu, X.E., Morgan, J.D., Hershberger, P.M., White, R.E., Gasparski, C.A., Kim, N., Shrum, G.P., Ramberger, N.R., Ma, X., O’Hara, T.L., Prohotsky, D.L., Anthony, D.R., Matson, P.A., Davis, B.W., DeVries, C.A., Koenigs, P.M., Paule, S.M., Twinem, T.L., Zoutendam, P.H., Imbus, R., Leunk, R.D., and Demuth, Jr., T.P., 1996, Multifunctional quinolonyl-penem carbamates and their antibacterial activities, 36th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. F168, New Orleans.
Hwu, J.R., Moshfegh, A.A., Tsay, S.-C, Lin, C.C., Tseng, W.N., Azaripour, A., Mottaghian, H., and Hakimelahi, G.H., 1997, Cephalosporin 3′-phloroglucide esters and 7-(phloroglucamido)cephalosporins as novel antibacterial agents, J. Med. Chem, 40:3434–41.
Jabes, D., Rossi, R., Bruna, C.D., Perrone, E., Alpegiani, M., Andreini, B.R., Visentin, G., Zarini, R., and Franceschi, G., 1993, Activity of new penems against defined MRSA strains, Bioorg. Med. Chem. Lett, 3(11):2165–70.
Jones, R.N., Barry, A.L., and Thornsberry, C., 1989, Antimicrobial activity of Ro 23-9424, a novel ester-linked co-drug of fleroxacin and desacetylcefotaxime, Antimicrob. Agents Chemother, 33(6):944–50.
Jung, M.E., and Light, L.A., 1982, Preparation of iodoallylic alcohols via hydrostannylation: spectroscopic proof of structures, Tetrahedron Lett, 23(38):3851–4.
Keith, D.D., Albrecht, H.A., Beskid, G., Chan, K.K., Christenson, J.G., Cleeland, R., Deitcher, K., Delaney, M., Georgopapadakou, N.H., Konzelmann, F., Okabe, M., Pruess, D., Rossman, P., Specian, A., Then, R., Wei, C.-C, and Weigele, M., 1993, Mechanism-based dual-action cephalosporins, Spec. Publ.-R. Soc. Chem, 119 (Recent Advances in the Chemistry of Anti-Infective Agents):79–92.
Kim, K.W., Kang, J.H., and Park, C.-H., 1993, Novel cephalosporin compounds, WO 9315084.
Koenigs, P., Paule, S., Shah, S., DeVries, C., Davis, B., Hu, X.E., White, R.E., Ma, X., Shrum, G.P., Stanton, K., Demuth, Jr., T.P., and Kraft, W.G., 1993, Structure-activity relationships for quinolonyl-lactam antibacterial binding to Staphylococcus aureus penicillin-binding proteins, 37th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. F194, Toronto, Canada.
Kraft, W.G., Leunk, R.D., McKeever, H.D., DeVries, C.A., Gray, J.L., Gasparski, C.M., Ma, X., Matson, P.A., Shrum, G.P., and Demuth, Jr., T.P., 1997, In vitro activity of quinolonyl-cephem amines, 37th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. F195, Toronto, Canada.
La, S., Jung, M., Kim, W., and Jee, U., 1993, Synthesis and antibacterial activity of cephalosporin 3′-quinolone dithiocarbamate, Yakhak Hoechi, 37(2): 136–42.
La, S., Kong, J., Kim, W., and Jee, U., 1993, Physicochemical properties, stabilities, and pharmacokinetics of cephalosporin 3′-quinolone dithiocarbamate, Yakhak Hoechi, 37(6):638–46.
Levy, S.B., 1998, The challenge of antibiotic resistance, Scientific American, March:46–53.
Ma, X., Davis, B.W., O’Hara, T.L., Anthony, D.R., Billings, D.M., Matson, P.A., White, R.E., Krauss, H.J., Berk, J.D., Wood, N.A., Loenigs, P.M., Shah, S.K., Shinabarger, D.L., Twinem, T.L., McOsker, C.C., Kraft, W.G., Rourke, F.J., and Demuth, Jr., T.P., 1994, Synthesis and multifunctional antibacterial activity of new quinolonyl-cephem 3°-amines, 34th Interscience Conf. Antimicrob. Agents Chemother, Orlando, FL.
Ma, X., White, R.E., Matson, P.A., DeVries, C.A., Switzer, A.G., Hu, X.E., Hershberger, P.M., Prohotsky, D.L., Anthony, D.R., O’Hara, T.L., Koenigs, P.M., Davis, B.W., Twinem, T.L., Kraft, W.G., Leunk, R.D., and Demuth, Jr., T.P., 1996, Synthesis and multifunctional antibacterial activity of amine-linked quinolonyl penems, 36th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. F167, New Orleans, LA.
Mallalieu, N.L.., Bierman, J.C., Emig, J.E., Dirr, M.K., Baker, T.R., Tirey, D.A., Zoutendam, P.H., Demuth, Jr., T.P., Hu, X.E., Gray, J.L., Shrum, G.P., Matson, P.A., Ma, X., White, R.E., and Leunk, R.D., 1997, Prediction of the pharmacokinetics and dosing schedule of quinolonyl-lactam (QL) antibacterial s in humans from data obtained in animals, 37th Interscience Conf Antimicrob. Agents Chemother, Abstr. No. F196, Toronto, Canada.
Mallalieu, N.L., Dorsey, J.S., Emig, J.E., Bierman, J.C., Dirr, M.K., Tirey, D.A., Zoutendam, P.H., Demuth, Jr., T.P., and Leunk, R.D., 1997, Comparison of the pharmacokinetics of penem versus cephem quinolonyl-lactam (QL) antibacterials in three mammalian species, Pharmaceutical Research, 14(11):S–363, Abstr. No. 2453.
Meyer, D.L., Jungheim, L.N., Mikolajczyk, S.D., Shephard, T.A., Starling, J.J., and Ahlem, C.N., 1992, Preparation and characterization of a β-lactamase-Fab’ conjugate for the site-specific activation of oncolytic agents, Bioconjugate Chem, 3:42–8.
Mielke, B., Philipps, T., Bremm, K., and Endermann, R., 1996, Beta-lactam derivatives of quinolonecarboxylic acids as bactericides, DE 4435478.
Miyamoto, T., Matsumoto, J., Chiba, K., Egawa, H., Shibamori, K., Minamida, A., Nishimura, Y., Okada, H., Kataoka, M., Fujita, M., Hirose, T., and Nakano, J., 1990, Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including Sparfloxacin, a new quinolone antibacterial agent with improved potency, J. Med. Chem, 33:1645–56.
Mobashery, S., and Johnston, M., 1987, Inactivation of alanine racemase by β-chloro-L-alanine released enzymati-cally from amino acid and peptide C10-esters of desacetylcephalothin, Biochemistry, 26:5878–84.
Mobashery, S., and Johnston, M., 1986, Reactions of Escherichia coli TEM β-lactamase with cephalothin and with C10-dipeptidyl cephalosporin esters, J. Biol. Chem, 261:7879–87.
Mobashery, S., and Johnston, M., 1986, Preparation of ceph-3-em esters unaccompanied by Δ2 → Δ3 isomerization of the cephalosporin, J. Org. Chem, 51:4723.
Mobashery, S., Lerner, S.A., and Johnston, M., 1986, Conscripting β-lactamase for use in drug delivery. Synthesis and biological activity of a cephalosporin C10-ester of an antibiotic dipeptide, J. Am. Chem. Soc, 108:1685–86.
Nishimura, T., Yoshimura, Y., Yamaoka, M., Kawai, T., and Miyake, A., 1991, Studies on condensed-heterocyelic azolium cephalosporins, J. Antibiotics, 44:1371–93.
O’Callaghan, C.H., Sykes, R.B., and Staniforth, S.E., 1976, A new cephalosporin with a dual mode of action, An-timicrob. Agents Chemother, 10:245–8.
Pace, J., Bertasso, A., and Georgopapadakou, N.H., 1991, Escherichia coli resistant to cephalosporins and qui-nolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424, Antimicrob. Agents Chemother, 35(5):910–15.
Page, M.I., 1984, The mechanisms of reactions of β-lactam antibiotics, Acc. Chem. Res, 17:144–51.
Page, M.I., and Proctor, P., 1984, Mechanism of β-lactam ring opening in cephalosporins, J. Am. Chem. Soc, 106:3820–25.
Petersen, U., Schrock, W., Haebich, D., Krebs, A., Schenke, T., Philipps, T., Grohe, K., Endermann, R., Bremm, K., and Metzger, K.G., 1994, Quinolonecarboxylic acid beta-lactam antibiotics, EP 591808.
Petersen, U., Schrock, W., Haebich, D., Krebs, A., Schenke, T., Philipps, T., Grohe, K., Endermann, R., Bremm, K., and Metzger, K.G., 1994, Preparation of penemylmethyl and cephalosporinylmethyl 7-(diazabicy-clonono)quinolonecarboxylates as bactericides, DE 4234330.
Rolston, K.V.I., Nguyen, H.T., Ho, D.H., LeBlanc, B., and Bodey, G., 1992, In vitro activity of Ro 23-9424, a dual action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents, Antimicrob. Agents Chemother, 36(4):879–82.
Rosen, T., Chu, D.T.W., Lico, I.M., Fernandes, P.B., Shen, L., Borodkin, S., and Pernet, A.G., 1988, Asymmetric synthesis and properties of the enantiomers of the antibacterial agent 7-(3-aminopyrrolidin-1-yl)-1-(2,4-di-fluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride, J. Med. Chem, 31:1586–90.
Rourke, F.J., Davis, B.W., Kraft, W.G., White, R.E., McOsker, C.C., O’Hara, T.L., and Demuth, Jr., T.P., 1993, In vitro activity of two new quinolonyl-penem carbamates, 33rd Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. 1489, New Orleans.
Rourke, F.J., Davis, B.W., Kraft, W.G., White, R.E., McOsker, C.C., Walling, M.A., Andersen, J.A., Salvagno, A.M., Fitzpatrick, P.M., Jamieson, L.A., and Demuth, Jr., T.P., 1992, Evaluation of new quinolonyl penem carbamates, 32nd Interscience Conf. on Antimicrob. Agents Chemother, Abstr. No. 772, Anaheim, CA.
Russell, A.D., and Fountain, R.H., 1971, Aspects of the mechanism of action of some cephalosporins, J. Bacteriol, 106:65–69.
Sanchez, J.P., Domagala, J.M., Hagen, S.E., Heifetz, C.L., Hutt, M.R., Nichols, J.B., and Trehan, A.K., 1988, Qui-nolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-ear-boxylic acids and 1,8-naphthyridine-3-carboxylic acids, J. Med. Chem, 31:983–91.
Shih, D.H., Baker, F., Cama L., and Christensen, B.G., 1984, Synthetic carbapenem antibiotics I. 1-β-methylcar-bapenem, Heterocycles, 21(1):29–40.
Silver, L.L., and Bostian, K.A., 1993, Discovery and Development of new antibiotics: the problem of antibiotic resistance, Antimicrob. Agents Chemother, 37(3):377–83.
Squires, E., and Christenson, J.G., 1991, Ro 23-9424, Drugs of the Future, 16:620–3.
Stocksdale, M.G., Ramurthy S., and Miller, M.J., 1998, Asymmetric total synthesis of an important 3-(hy-droxymethyl)carbacephalosporin, J. Org, Chem, 63:1221–25.
Sunagawa, M., Matsumura, H., Inoue, T., Fukasawa M., and Kato, M., 1990, A novel carbapenem antibiotic, SM-7338 structure-activity relationships, J. Antibiotics, 43(5):519–32.
Svensson, H.P., Kadow, J.F., Vrudhula, V.M., Wallace, P.M., and Senter, P.D., 1992, Monoclonal antibody-β-lac-tamase conjugates for the activation of a cephalosporin mustard prodrug, Bioconjugate Chem, 3:176–81.
Veinberg, G., Shestakova, I., Petrulanis, L., Grigan, N., Musel, D., Zeile, D., Kanepe, I., Domrachova, I., Kalv-insh, I., Strakovs, A., and Lukevics, E., 1997, Synthesis and evaluation of dual action cephalosporins as elastase inhibitors, Bioorg. Med. Chem. Lett, 7(7):843–6.
White, R.E., Demuth, Jr., T.P., Berk, J.D., Tietjen, R.A., Jamieson, L.A., Kraft, W.G., McOsker, C.C., Davis, B.W., Rourke, F.J., Koenigs, P., Shah, S., Shinabarger, D.L., Shrum, G.P., Walling, M.A., and White, A.H., 1993, Preparation and comparative antibacterial activity of quinolonyl-cephem amines and carbamates, 33rd Interscience Conf Antimicrob. Agents Chemother, Abstr. No. 1491, New Orleans, LA.
White, R.E., Gasparski, C.M., Kim, N., Hu, X.E., Shrum, G.P., Lockhart, N.R., Switzer, A.G., Hershberger, P.M., Koenigs, P.M., Paule, S.M., Twinem, T.L., DeVries, C.A., Zoutendam, P.H., Imbus, R., Kraft, W.G., Leunk, R.D., and Demuth, Jr., T.P., 1997, Synthesis and biological evaluation of quinolonyl-carbacephalosporin antibacterials, 37th Interscience Conf. Antimicrob. Agents Chemother, Abstr. No. F193, Toronto, Canada.
Yamanaka, H., Chiba, T., Kawabata, K., Takasugi, H., Masugi, T., and Takaya, T., 1985, Studies on β-lactam antibiotics, J. Antibiotics, 38(12): 1738–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hershberger, P.M., Demuth, T.P. (1998). Concept, Design, and Preclinical Evaluation of Quinolonyl Lactam Antibacterials. In: Rosen, B.P., Mobashery, S. (eds) Resolving the Antibiotic Paradox. Advances in Experimental Medicine and Biology, vol 456. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4897-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4897-3_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7220-2
Online ISBN: 978-1-4615-4897-3
eBook Packages: Springer Book Archive